Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Lefebvre

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|May 15, 2015
Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitorsEric Therrien, Guillaume Larouche, Natalie Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2008
Sulfamides as novel histone deacetylase inhibitorsAmal Wahhab, David Smil, Alain Ajamian, et al.
Journal of Medicinal Chemistry|October 19, 2007
Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivityOscar M Moradei, Tammy C Mallais, Sylvie Frechette, et al.
Molecular Cancer Therapeutics|April 17, 2008
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivoMarielle Fournel, Claire Bonfils, Yu Hou, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2009
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsStéphane Raeppel, Stephen Claridge, Oscar Saavedra, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsMichael Mannion, Stéphane Raeppel, Stephen Claridge, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinasesStephen Claridge, Franck Raeppel, Marie-Claude Granger, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|May 15, 2015
Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitorsEric Therrien, Guillaume Larouche, Natalie Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2008
Sulfamides as novel histone deacetylase inhibitorsAmal Wahhab, David Smil, Alain Ajamian, et al.
Journal of Medicinal Chemistry|October 19, 2007
Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivityOscar M Moradei, Tammy C Mallais, Sylvie Frechette, et al.
Molecular Cancer Therapeutics|April 17, 2008
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivoMarielle Fournel, Claire Bonfils, Yu Hou, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2009
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsStéphane Raeppel, Stephen Claridge, Oscar Saavedra, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsMichael Mannion, Stéphane Raeppel, Stephen Claridge, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinasesStephen Claridge, Franck Raeppel, Marie-Claude Granger, et al.
Pageof 2